Company Filing History:
Years Active: 2009-2010
Title: Selma Marianne Hensen: Innovator in Veterinary Pharmaceuticals
Introduction
Selma Marianne Hensen is a notable inventor based in Mook, Netherlands. She has made significant contributions to the field of veterinary pharmaceuticals, particularly in the treatment of mastitis in nonhuman mammals. With a total of 2 patents, her work has the potential to impact animal health positively.
Latest Patents
Hensen's latest patents include a pharmaceutical composition for the treatment of clinical mastitis. This composition comprises an antibacterial agent and prednisolone, with at least 20 mg of prednisolone for effective intramammary administration. Another significant invention relates to nucleic acid sequences encoding a 22.5 kD protein, which has applications in vaccines and diagnostics. This invention encompasses various components, including DNA fragments, recombinant DNA molecules, and diagnostic kits.
Career Highlights
Selma Hensen is associated with Intervet International B.V., a company that specializes in veterinary pharmaceuticals. Her work at Intervet has allowed her to focus on innovative solutions for animal health challenges.
Collaborations
Throughout her career, Hensen has collaborated with notable colleagues, including Petrus Johannes Maria Nuijten and Peter Gerardus Franciscus Cox. These collaborations have contributed to her success in developing impactful veterinary solutions.
Conclusion
Selma Marianne Hensen's contributions to veterinary pharmaceuticals through her innovative patents demonstrate her commitment to improving animal health. Her work continues to pave the way for advancements in the treatment and prevention of diseases in nonhuman mammals.